| Mr Alan Kenneth Ward, MOTRL | |
|
802 S 200 W, Blanding, UT 84511-3910 | |
| (435) 678-3869 | |
| (435) 678-3769 |
| Full Name | Mr Alan Kenneth Ward |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapy |
| Experience | 20 Years |
| Location | 802 S 200 W, Blanding, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811965817 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5009456-4201 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Precision Rehabilitation Pc | 7113027244 | 5 |
News Archive
The Brain and Spinal Injury Trust Fund Commission announces its annual meeting will take place on Thursday, August 27, 2009 at 10:30 a.m. on the campus of Georgia Military College - Legislative Chamber/Old Capitol Building in Milledgeville, GA.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
Fitch Ratings has assigned a 'AA' rating to the expected issuance of approximately $225 million of Indiana Finance Authority Health System revenue bonds, series 2009A (Sisters of St. Francis Health Services, Inc. Obligated Group; (SSFHS). In addition, Fitch affirms the outstanding 'AA' long-term ratings on approximately $950.3 million of bonds issued for SSFHS.
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis.
› Verified 9 days ago
| Provider Name | Utah Navajo Health System Incorporated |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1811991151 PECOS PAC ID: 1658275649 Enrollment ID: O20031121000239 |
News Archive
The Brain and Spinal Injury Trust Fund Commission announces its annual meeting will take place on Thursday, August 27, 2009 at 10:30 a.m. on the campus of Georgia Military College - Legislative Chamber/Old Capitol Building in Milledgeville, GA.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
Fitch Ratings has assigned a 'AA' rating to the expected issuance of approximately $225 million of Indiana Finance Authority Health System revenue bonds, series 2009A (Sisters of St. Francis Health Services, Inc. Obligated Group; (SSFHS). In addition, Fitch affirms the outstanding 'AA' long-term ratings on approximately $950.3 million of bonds issued for SSFHS.
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis.
› Verified 9 days ago
| Provider Name | Precision Rehabilitation Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376754929 PECOS PAC ID: 7113027244 Enrollment ID: O20070703000036 |
News Archive
The Brain and Spinal Injury Trust Fund Commission announces its annual meeting will take place on Thursday, August 27, 2009 at 10:30 a.m. on the campus of Georgia Military College - Legislative Chamber/Old Capitol Building in Milledgeville, GA.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
Fitch Ratings has assigned a 'AA' rating to the expected issuance of approximately $225 million of Indiana Finance Authority Health System revenue bonds, series 2009A (Sisters of St. Francis Health Services, Inc. Obligated Group; (SSFHS). In addition, Fitch affirms the outstanding 'AA' long-term ratings on approximately $950.3 million of bonds issued for SSFHS.
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Alan Kenneth Ward, MOTRL Po Box 745, Blanding, UT 84511-0745 Ph: (435) 678-3869 | Mr Alan Kenneth Ward, MOTRL 802 S 200 W, Blanding, UT 84511-3910 Ph: (435) 678-3869 |
News Archive
The Brain and Spinal Injury Trust Fund Commission announces its annual meeting will take place on Thursday, August 27, 2009 at 10:30 a.m. on the campus of Georgia Military College - Legislative Chamber/Old Capitol Building in Milledgeville, GA.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
Fitch Ratings has assigned a 'AA' rating to the expected issuance of approximately $225 million of Indiana Finance Authority Health System revenue bonds, series 2009A (Sisters of St. Francis Health Services, Inc. Obligated Group; (SSFHS). In addition, Fitch affirms the outstanding 'AA' long-term ratings on approximately $950.3 million of bonds issued for SSFHS.
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis.
› Verified 9 days ago
Shelby Lyn Webb, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 802 S 200 W, Blanding, UT 84511 Phone: 435-678-3869 |